CN117981012A - 用于提供与进展里程碑相对应的准确患者数据以提供治疗选项和结果跟踪的系统和方法 - Google Patents
用于提供与进展里程碑相对应的准确患者数据以提供治疗选项和结果跟踪的系统和方法 Download PDFInfo
- Publication number
- CN117981012A CN117981012A CN202280060905.0A CN202280060905A CN117981012A CN 117981012 A CN117981012 A CN 117981012A CN 202280060905 A CN202280060905 A CN 202280060905A CN 117981012 A CN117981012 A CN 117981012A
- Authority
- CN
- China
- Prior art keywords
- fact
- patient
- candidate
- facts
- progress
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 149
- 238000011282 treatment Methods 0.000 title claims description 83
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 115
- 201000010099 disease Diseases 0.000 claims abstract description 108
- 230000002452 interceptive effect Effects 0.000 claims abstract description 54
- 230000009467 reduction Effects 0.000 claims description 54
- 239000003550 marker Substances 0.000 claims description 37
- 238000003745 diagnosis Methods 0.000 claims description 35
- 238000011161 development Methods 0.000 claims description 33
- 238000012360 testing method Methods 0.000 claims description 32
- 230000008859 change Effects 0.000 claims description 28
- 239000000090 biomarker Substances 0.000 claims description 14
- 238000004891 communication Methods 0.000 claims description 11
- 238000004393 prognosis Methods 0.000 claims description 11
- 208000035475 disorder Diseases 0.000 claims description 7
- 230000002250 progressing effect Effects 0.000 claims description 4
- 230000004614 tumor growth Effects 0.000 claims description 4
- 238000004458 analytical method Methods 0.000 description 42
- 206010028980 Neoplasm Diseases 0.000 description 38
- 230000008569 process Effects 0.000 description 32
- 238000012795 verification Methods 0.000 description 26
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 24
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 24
- 201000011510 cancer Diseases 0.000 description 24
- 238000003860 storage Methods 0.000 description 17
- 238000012545 processing Methods 0.000 description 14
- 238000010586 diagram Methods 0.000 description 13
- 238000004364 calculation method Methods 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 230000036541 health Effects 0.000 description 10
- 206010061289 metastatic neoplasm Diseases 0.000 description 9
- 230000005750 disease progression Effects 0.000 description 8
- 208000037819 metastatic cancer Diseases 0.000 description 8
- 208000011575 metastatic malignant neoplasm Diseases 0.000 description 8
- 206010061818 Disease progression Diseases 0.000 description 7
- 102000015694 estrogen receptors Human genes 0.000 description 7
- 108010038795 estrogen receptors Proteins 0.000 description 7
- 230000000750 progressive effect Effects 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 230000000670 limiting effect Effects 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 238000004590 computer program Methods 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 230000001394 metastastic effect Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 206010006187 Breast cancer Diseases 0.000 description 4
- 208000026310 Breast neoplasm Diseases 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 238000009795 derivation Methods 0.000 description 4
- 230000002085 persistent effect Effects 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 239000008186 active pharmaceutical agent Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000007481 next generation sequencing Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 description 3
- 206010027476 Metastases Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 238000011005 laboratory method Methods 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 102000003998 progesterone receptors Human genes 0.000 description 2
- 108090000468 progesterone receptors Proteins 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000010507 Adenocarcinoma of Lung Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010055113 Breast cancer metastatic Diseases 0.000 description 1
- 101100314454 Caenorhabditis elegans tra-1 gene Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008805 Chromosomal abnormalities Diseases 0.000 description 1
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000029027 Musculoskeletal and connective tissue disease Diseases 0.000 description 1
- 102100035348 Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000013501 data transformation Methods 0.000 description 1
- 238000013503 de-identification Methods 0.000 description 1
- 238000003066 decision tree Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000009093 first-line therapy Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 201000005249 lung adenocarcinoma Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000010295 mobile communication Methods 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000000683 nonmetastatic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000012913 prioritisation Methods 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- APTZNLHMIGJTEW-UHFFFAOYSA-N pyraflufen-ethyl Chemical compound C1=C(Cl)C(OCC(=O)OCC)=CC(C=2C(=C(OC(F)F)N(C)N=2)Cl)=C1F APTZNLHMIGJTEW-UHFFFAOYSA-N 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/06—Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
- G06Q10/063—Operations research, analysis or management
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F3/00—Input arrangements for transferring data to be processed into a form capable of being handled by the computer; Output arrangements for transferring data from processing unit to output unit, e.g. interface arrangements
- G06F3/01—Input arrangements or combined input and output arrangements for interaction between user and computer
- G06F3/048—Interaction techniques based on graphical user interfaces [GUI]
- G06F3/0484—Interaction techniques based on graphical user interfaces [GUI] for the control of specific functions or operations, e.g. selecting or manipulating an object, an image or a displayed text element, setting a parameter value or selecting a range
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Business, Economics & Management (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Human Resources & Organizations (AREA)
- Strategic Management (AREA)
- Data Mining & Analysis (AREA)
- General Business, Economics & Management (AREA)
- Economics (AREA)
- Entrepreneurship & Innovation (AREA)
- Theoretical Computer Science (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Operations Research (AREA)
- Quality & Reliability (AREA)
- Tourism & Hospitality (AREA)
- Game Theory and Decision Science (AREA)
- Educational Administration (AREA)
- Development Economics (AREA)
- Databases & Information Systems (AREA)
- Marketing (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Human Computer Interaction (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17/375,916 US20210343420A1 (en) | 2020-01-09 | 2021-07-14 | Systems and methods for providing accurate patient data corresponding with progression milestones for providing treatment options and outcome tracking |
| US17/375916 | 2021-07-14 | ||
| PCT/US2022/037017 WO2023287920A1 (fr) | 2021-07-14 | 2022-07-13 | Systèmes et procédés pour fournir des données de patient précises correspondant à des repères de progression pour fournir des options de traitement et un suivi de résultats |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117981012A true CN117981012A (zh) | 2024-05-03 |
Family
ID=84920406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202280060905.0A Pending CN117981012A (zh) | 2021-07-14 | 2022-07-13 | 用于提供与进展里程碑相对应的准确患者数据以提供治疗选项和结果跟踪的系统和方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4371132A1 (fr) |
| JP (1) | JP2024529876A (fr) |
| KR (1) | KR20240032920A (fr) |
| CN (1) | CN117981012A (fr) |
| AU (1) | AU2022311798A1 (fr) |
| CA (1) | CA3225678A1 (fr) |
| IL (1) | IL310082A (fr) |
| WO (1) | WO2023287920A1 (fr) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011501276A (ja) * | 2007-10-12 | 2011-01-06 | ペイシェンツライクミー， インコーポレイテッド | 健康関連の転帰を予測するためのオンラインコミュニティを使用した自己改善方法 |
| US8694335B2 (en) * | 2011-02-18 | 2014-04-08 | Nuance Communications, Inc. | Methods and apparatus for applying user corrections to medical fact extraction |
| US10783448B2 (en) * | 2015-08-07 | 2020-09-22 | Flatiron Health, Inc. | Extracting facts from unstructured data |
| US10949395B2 (en) * | 2016-03-30 | 2021-03-16 | Salesforce.Com, Inc. | Cross objects de-duplication |
-
2022
- 2022-07-13 EP EP22842831.4A patent/EP4371132A1/fr active Pending
- 2022-07-13 WO PCT/US2022/037017 patent/WO2023287920A1/fr active Application Filing
- 2022-07-13 AU AU2022311798A patent/AU2022311798A1/en active Pending
- 2022-07-13 KR KR1020247004016A patent/KR20240032920A/ko unknown
- 2022-07-13 CA CA3225678A patent/CA3225678A1/fr active Pending
- 2022-07-13 IL IL310082A patent/IL310082A/en unknown
- 2022-07-13 JP JP2024501769A patent/JP2024529876A/ja active Pending
- 2022-07-13 CN CN202280060905.0A patent/CN117981012A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4371132A1 (fr) | 2024-05-22 |
| KR20240032920A (ko) | 2024-03-12 |
| CA3225678A1 (fr) | 2023-01-19 |
| WO2023287920A1 (fr) | 2023-01-19 |
| JP2024529876A (ja) | 2024-08-14 |
| WO2023287920A9 (fr) | 2023-12-07 |
| AU2022311798A1 (en) | 2024-01-25 |
| IL310082A (en) | 2024-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210343429A1 (en) | Informatics platform for integrated clinical care | |
| JP6674375B2 (ja) | 臨床転帰トラッキング及び分析 | |
| US20190156947A1 (en) | Automated information collection and evaluation of clinical data | |
| US20210343420A1 (en) | Systems and methods for providing accurate patient data corresponding with progression milestones for providing treatment options and outcome tracking | |
| US20140379379A1 (en) | System and method for real time clinical questions presentation and management | |
| US11984227B2 (en) | Automatically determining a medical recommendation for a patient based on multiple medical images from multiple different medical imaging modalities | |
| JP7355415B2 (ja) | 臨床転帰を改善し、総治療費を低減するためのｃｎａガイドケア | |
| Onega et al. | Accuracy of digital pathologic analysis vs traditional microscopy in the interpretation of melanocytic lesions | |
| JP2019530098A (ja) | 協調的な変異選択及び治療合致レポートのための方法及び装置 | |
| US20230110360A1 (en) | Systems and methods for access management and clustering of genomic, phenotype, and diagnostic data | |
| Wang et al. | EHR STAR: the state‐of‐the‐art in interactive EHR visualization | |
| Bigus et al. | Information technology for healthcare transformation | |
| Vathy-Fogarassy et al. | Multi-level process mining methodology for exploring disease-specific care processes | |
| Valero-Ramon et al. | Analytical exploratory tool for healthcare professionals to monitor cancer patients’ progress | |
| Giannoula et al. | Exploring long-term breast cancer survivors’ care trajectories using dynamic time warping-based unsupervised clustering | |
| US20190295726A1 (en) | Systems and methods for monitoring subjects for hereditary cancers | |
| CN117981012A (zh) | 用于提供与进展里程碑相对应的准确患者数据以提供治疗选项和结果跟踪的系统和方法 | |
| US20210217527A1 (en) | Systems and methods for providing accurate patient data corresponding with progression milestones for providing treatment options and outcome tracking | |
| Maramis et al. | Applying semantic technologies in cervical cancer research | |
| Robertson et al. | It Is in Our DNA: Bringing Electronic Health Records and Genomic Data Together for Precision Medicine | |
| US20230395241A1 (en) | Methods and systems for patient discharge management | |
| Swaminathan et al. | Data-driven extraction of unstructured electronic health records to evaluate glioblastoma treatment patterns | |
| Sintchenko et al. | Developing decision support systems in clinical bioinformatics | |
| Wenham et al. | The creation of an integrated health-information platform: building the framework to support personalized medicine | |
| Jaffray et al. | Cancer informatics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |